Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-016510
Filing Date
2025-02-24
Accepted
2025-02-24 16:15:51
Documents
1
Period of Report
2025-02-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm257355-1_4seq.html 4  
1 OWNERSHIP DOCUMENT tm257355-1_4seq.xml 4 6773
  Complete submission text file 0001104659-25-016510.txt   8241
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 400 CAMBRIDGE MA 02140
Business Address
Jorgensen Nathan D. (Reporting) CIK: 0001842523 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37625 | Film No.: 25657193